Press Releases

Fortis Life Sciences, a provider of high-quality reagents and custom services for discovery, development, and manufacturing, has expanded its international presence by opening an office in Seoul, South Korea. South Korea's pharmaceutical, diagnostic, and life science industry has grown to become one of the most comprehensive markets in Asia-Pacific, with increased demand from within and outside the region. Therefore, this strategic milestone is a significant development to bolst

Zivo Bioscience, Inc., a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced plans to create ZIVOLife LLC (“ZIVOLife”), a newly formed wholly-owned subsidiary, to streamline the Company’s corporate structure, better capitalize on the global agtech market opportunity and accelerate progress toward generating revenue from the Company’s proprietary a

Ahead of the world’s largest pharma event, CPHI Frankfurt – hosted at the Frankfurt Messe (1-3 November, 2022) – part i of the CPHI Annual Report looks ahead at the opportunities for biologics production and CMOs in 2023. Having already benefitted from a Covid-based boom in the last two years, outsourcing of biologics globally is set to continue growing significantly in 2023 – with no production cliff expected [as Covid contracts reduce in scale]. The report&

Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO), today announced that it will operationalize its state-of-the-art formulation manufacturing facility in the Mallapur campus, Hyderabad, India by January 2023. The 12,000 square feet new facility will strengthen the company’s ability to deliver clinical supplies to customers through its integrated drug substance and drug product development and manufacturing. The new plant will include a wide

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) indications, today announces that the US Food and Drug Administration (FDA) has granted Fast Track designation to its mGluR5 inhibitor basimglurant (NOE-101) for the treatment of trigeminal neuralgia (TN). Fast Track designation aims at facilitating the development and expediting the review of drugs to treat serious conditions with clearly defined unmet medical needs, with the purpose to bring i

Univar Solutions Inc., a leading global solutions provider to users of specialty ingredients and chemicals, today announced the addition of four pharmaceutical ingredient labs at its flagship Solution Centers in Houston, Texas; Osasco - São Paulo, Brazil; Mexico City, Mexico; and Essen, Germany. The new facilities, designed to foster innovation and growth for customers in life science markets, will provide technical services such as formulation and prototype development, performance an

Eucure (Beijing) Biopharma Co., Ltd., a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd., announced today that the company has entered into a worldwide licensing agreement with Syncromune, Inc. (“Syncromune”), a US-based clinical stage biopharmaceutical company, for the development and commercialization of intratumoral immunotherapies along with Syncromune’s Syncrovax™ technology. Under the terms of the agreement, Syncromune will acqu

APCER Life Sciences, the preferred services provider for Pharmaceutical and Biotech companies looking for compliance solutions across the drug life cycle, has been awarded the ISO 9001:2015 Quality Management System certification. The globally recognized and accepted standard for Quality Management System (QMS) has been authorized by Intertek Certification Limited, UKAS (The United Kingdom Accreditation Service – ISO accreditation body). The certification validates APCER&rsquo

Austrian solution provider Single Use Support GmbH is expanding its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company leverages its know-how to provide reliable process solutions in the field of biopharmaceutical fluid management, continuing to pursue its vendor-agnostic approach. Single Use Support GmbH brings IRIS single-use bags to the biopharmaceutical market. The company’s extensive expertise in the behavior of d

Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced positive topline efficacy and safety data from the Phase 3 RAPID clinical trial of etripamil, the Company's investigational calcium channel blocker, in patients with paroxysmal supraventricular tachycardia (PSVT). "PSVT is an unpredictable, disruptive burden on patients, with current interventions restricted to